Overview
Discounted cash flow
Income / accounting-based
Multiples & assets
Scenario
Toolbox
Weighted blend
$305.71
+24.54% vs spot
Buy
Spot price
$245.47
Mkt cap $8.94B
subtle cardAnalyst PT consensus
$277.89
+13.21% vs spot
subtle cardMethods covered
19 / 20
9 in blend
subtle cardFootball field
FDS · fair-value range by method
Method comparison
FDS · fair value by valuation framework
| Method | Category | Fair value | Range | vs spot | Weight | Driver | Conf. |
|---|---|---|---|---|---|---|---|
| DCF · FCFF | dcf | $1,211.52 | $717.45 – $2,542.31 | +393.55% | 6.0% | WACC 5.6%, g₀=12.3%, gₗ=3.4% | high |
| DCF · FCFE | dcf | $615.72 | $435.13 – $927.73 | +150.83% | 11.9% | kₑ 7.5%, g₀=12.3%, gₗ=3.4% | high |
| DDM · Gordon | ddm | $117.47 | $94.74 – $154.55 | -52.15% | 11.9% | D₁ 4.74, kₑ 7.5%, gₗ 3.4% | med |
| DDM · H-model | ddm | $168.37 | $122.05 – $243.95 | -31.41% | — | D₀ 4.74, g₀=12.3%, gₗ=3.4%, H 5y | med |
| DDM · multi-stage | ddm | $143.80 | $122.23 – $165.37 | -41.42% | 11.9% | 5y schedule 12.3% → 3.4%, kₑ 7.5% | high |
| Residual income | income | $97.54 | $85.84 – $109.25 | -60.26% | 21.4% | BV 64.73, ROE 27.3% → kₑ | high |
| EVA / MVA | income | $934.14 | $822.04 – $1,046.24 | +280.55% | 7.1% | IC 3.4B, WACC 5.6% | high |
| Excess returns | income | $118.83 | $104.57 – $133.09 | -51.59% | 14.3% | BV 64.73, ROE 27.3% | high |
| P/E · sector | multiple | $217.70 | $191.58 – $243.82 | -11.31% | 9.5% | EPS 15.55 × peer P/E 14.0 | med |
| P/S · sector | multiple | $206.22 | $175.29 – $237.15 | -15.99% | — | Rev/sh 68.74 × peer P/S 3.00 | med |
| EV / EBITDA | multiple | $249.84 | $219.86 – $279.82 | +1.78% | — | EBITDA × peer 10.0× − ND 1.2B | high |
| EV / EBIT | multiple | $229.71 | $195.26 – $264.17 | -6.42% | — | EBIT × peer 12.0× − ND | med |
| EV / Sales | multiple | $139.14 | $118.27 – $160.01 | -43.32% | — | Sales × peer 2.55× − ND | med |
| PEG-anchored | multiple | $214.88 | $182.65 – $247.12 | -12.46% | — | PEG=1, fwd EPS g 13.8% | med |
| Earnings power | intrinsic | $285.16 | $250.94 – $319.38 | +16.17% | — | NOPAT / WACC, no growth | med |
| Graham revised | intrinsic | $508.67 | $432.37 – $584.98 | +107.22% | — | EPS×(8.5+2g)·4.4/Y | low |
| Lynch P/E=g | intrinsic | $191.72 | $162.96 – $220.48 | -21.90% | — | PE = g (12.3) | low |
| Book NAV | asset | $64.73 | $61.50 – $67.97 | -73.63% | 6.0% | (Assets − Liabilities) / Shares | high |
| Liquidation | asset | $29.50 | $25.08 – $33.93 | -87.98% | — | Cash 100% + non-cash 70% − Liab. | low |
| Reverse DCF | reverse | — | — | — | — | Implied g -17.7% · Pessimistic — market pricing decline | high |
Cost-of-capital build-up
CAPM cost of equity, after-tax cost of debt, WACC. Risk-free as of 2026-05-12.
| Risk-free rate (US 10y Treasury)rf | 4.46% |
| Equity beta (0.69)β | × 0.69 |
| Equity risk premiumERP | 4.46% |
| Cost of equity (CAPM)kₑ | 7.54% |
| Pre-tax cost of debtkd | 3.61% |
| Effective tax ratet | 18.4% |
| After-tax cost of debt | 2.95% |
| Equity weight$2.2B | 58.4% |
| Debt weight$1.6B | 41.6% |
| WACC | 5.63% |
Growth assumptions
Blended forward growth used as DCF default; terminal pegged to long-run nominal GDP.
| Analyst forward revenue growthFMP | 6.05% |
| Analyst forward EPS growthFMP | 13.82% |
| Historical 5y revenue CAGRFY | 9.90% |
| Historical 5y EPS CAGRFY | 10.69% |
| Sustainable g (ROE × retention)Δ | 19.99% |
| Blended near-term growth (g₀) | 12.33% |
| Terminal growth (gₗ) | 3.37% |
Sources
- FMP /analyst-estimates— 8 rows(as of 2023-08-31)
- Treasury rates · 10y— 4.46% rf(as of 2026-05-12)
- market_risk_premium · DB— 4.46% ERP(as of 2026-05-13)
- Sector multiple defaults— Financial Services (live sector PE unavailable)
- FMP /price-target-consensus— mean $277.89
This page is generated by a quantitative valuation engine for research purposes only and does not constitute investment advice. Methodology follows standard CFA / Damodaran frameworks; assumptions are driven by analyst consensus from Financial Modeling Prep and reported financial statements.